[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364025-105":59,"doc-detail-364025-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","orthogonal-dna-barcoding-enables-subpopulation-resolved-extracellular-vesicle-mirna-profiling","Orthogonal DNA barcoding enables subpopulation-resolved extracellular vesicle miRNA profiling","","Extracellular vesicle–associated microRNAs (EV-miRNAs) offer promise for liquid biopsy, but clinical utility is limited by EV heterogeneity and mixed origins of circulating miRNAs. DEEPER is a DNA-encoded orthogonal recognition platform that uses four aptamers to generate barcodes distinguishing 15 tumor-derived EV subpopulations, followed by targeted membrane fusion for in situ miRNA profiling. In a 60-sample gastric cancer cohort, DEEPER achieved 98.3% diagnostic accuracy and 95.5% accuracy for tumor invasiveness, supporting mechanistic links to tumor progression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/orthogonal-dna-barcoding-enables-subpopulation-resolved-extracellular-vesicle-mirna-profiling/364025/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/orthogonal-dna-barcoding-enables-subpopulation-resolved-extracellular-vesicle-mirna-profiling/364025.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does DEEPER address in EV-miRNA liquid biopsy?","Question",{"text":113,"@type":114},"DEEPER targets the clinical challenge that EV-miRNAs have reduced specificity due to EV heterogeneity and mixed miRNA origins in biofluids. It also aims to streamline workflows that are otherwise labor-intensive and time-consuming.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does DEEPER distinguish different extracellular vesicle subpopulations?",{"text":118,"@type":114},"DEEPER uses four aptamers targeting CD44, EGFR, HER2, and PD-L1 to generate orthogonal DNA barcodes. These barcodes distinguish 15 tumor-derived EV subpopulations.",{"name":120,"@type":111,"acceptedAnswer":121},"What performance did DEEPER achieve in the gastric cancer cohort?",{"text":122,"@type":114},"In a 60-sample cohort, DEEPER identified a high-performing GC-EV miRNA Prime signature with 98.3% diagnostic accuracy. The same profiling framework assessed tumor invasiveness with 95.5% accuracy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364025,1790484459,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","CANCER  \nOrthogonal DNA barcoding enables subpopulation-resolved extracellular vesicle miRNA profiling  \nYe Zhang1,2*†, Yitong Zhu1,2,3†, Yu Zhang1,2,3†, Shijin Peng1,2,3†, Diheng Wu4, Wenbin Li1,2, Tingting Ji1,2, Siting Chen1,2, Yuanhong Lin1,2,3, Huihong Yang1,2,3, Yuhang Guo1,2, Bo Li1,2, Chunchen Liu1,2, Bo Situ1,2,5*, Xiaohui Yan1,2,3*, Lei Zheng1,2,5*  \nExtracellular vesicle–associated microRNAs (EV-miRNAs) hold promise for liquid biopsy, but their clinical utility is hindered by EV heterogeneity. Here, we report DEEPER, a DNA-encoded orthogonal recognition platform for selective barcoding of tumor-derived EV subpopulations and in situ miRNA profiling. DEEPER uses four aptamers targeting Cluster of Differentiation 44 (CD44), Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Programmed Death-Ligand 1(PD-L1) to generate orthogonal barcodes that distinguish 15 EV subpopulations. Barcoded EVs then undergo targeted membrane fusion with liposome probes, enabling sensitive in situ analysis of subpopulation-specific miRNAs. In a 60-sample cohort of patients with gastric cancer (GC) and healthy donors (HDs), DEEPER identified a high-performing signature, GC-EV miRNA Prime, comprising EGFR+, EGFR+HER2+, and EGFR+HER2+CD44+ EVs, which achieved 98.3% diagnostic accuracy. The same profiling framework also assessed tumor invasiveness with 95.5% accuracy. Mechanistic studies further showed that these EV-miRNAs contribute to tumor progression. In summary, DEEPER not only confirmed the clinical application value of EV-miRNA–based liquid biopsy but also provided unique insights through the EV subpopulations into the mechanisms driving cancer development.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nMicroRNAs (miRNAs) are ∼22–nucleotide (nt), noncoding, singlestranded RNAs that modulate gene expression primarily by blocking the translation of target mRNAs or accelerating their decay (1, 2). Altered miRNA patterns are tightly linked to tumor development across many cancers and, accordingly, have been pursued as biomarkers for diagnosis, prognosis, and monitoring of therapeutic response (3, 4) . However, the clinical utility of miRNAs in liquid biopsy has been challenged as miRNAs in biofluids arise from multiple sources and carriers—including freely circulating molecules, ribonucleoprotein-bound forms, and species enclosed within distinct extracellular vesicle (EV) subpopulations (5, 6). This heterogeneity in origin reduces analytical specificity and has impeded the translation of miRNA assays from proof-of-concept studies to routine clinical practice. EVs are membrane-encapsulated particles produced via the endosomal system and multivesicular body biogenesis pathways (7, 8). Within EVs, miRNAs are selectively loaded and enriched, function as modulators of diverse physiological and pathological processes, and remainstable owing to protection by the lipid bilayer (9, 10). Notably, miRNAs  \n1department of laboratory Medicine, Guangdong Provincial Key laboratory of Precision Medical diagnostics, Guangdong engineering and technology Research center for Rapid diagnostic Biosensors, Guangdong Provincial Key laboratory of Single-cell and extracellular vesicles, nanfang hospital, Southern Medical University, Guangzhou 510515, P. R. china. 2Guangdong Provincial clinical Research center for laboratory Medicine, Guangzhou, china. 3Medical Research center of nanfang hospital, nanfang hospital, Guangdong Provincial Key laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, P. R. china. 4School of Biomedical engineering, Southern Medical University, Guangzhou, Guangdong 510515, P. R. china. 5State Key laboratory of Multi-organ inju","cbCaieYwE6R3lcyh","https://ap.wps.com/l/cbCaieYwE6R3lcyh","pdf",3649512,"English","# Introduction\n## MicroRNAs and liquid biopsy challenges\n## EV characteristics and EV-miRNA enrichment\n## Limitations of current assay workflows\n## Need for sensitive, streamlined tumor-derived EV-miRNA detection","[{\"question\":\"What problem does DEEPER address in EV-miRNA liquid biopsy?\",\"answer\":\"DEEPER targets the clinical challenge that EV-miRNAs have reduced specificity due to EV heterogeneity and mixed miRNA origins in biofluids. It also aims to streamline workflows that are otherwise labor-intensive and time-consuming.\"},{\"question\":\"How does DEEPER distinguish different extracellular vesicle subpopulations?\",\"answer\":\"DEEPER uses four aptamers targeting CD44, EGFR, HER2, and PD-L1 to generate orthogonal DNA barcodes. These barcodes distinguish 15 tumor-derived EV subpopulations.\"},{\"question\":\"What performance did DEEPER achieve in the gastric cancer cohort?\",\"answer\":\"In a 60-sample cohort, DEEPER identified a high-performing GC-EV miRNA Prime signature with 98.3% diagnostic accuracy. The same profiling framework assessed tumor invasiveness with 95.5% accuracy.\"}]","Orthogonal DNA barcoding enables subpopulation-resolved extracellular vesicle miRNA profiling | PDF",1790155185,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/511c692688c34c2734a6a4eef42c5691.webp",983,1250,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ffadf4fe6d154a5ff72f8b67f6416d0.webp",982,1249,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f70c8f64cbe853711fa48d64e4cf8918.webp",981,1248,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a11d2b5f226959dae56d149f82a8e57c.webp",980,1247]